Schukken, Y. H., et al. “Invited Review: The Role of Cow, Pathogen, and Treatment Regimen in the Therapeutic Success of Bovine Staphylococcus Aureus Mastitis”. Journal of Dairy Science, vol. 89, no. 6, 2006, pp. 1877-95, https://scholar2.islandarchives.ca/islandora/object/ir%3Air-batch6-4140.

Genre

  • Journal Article
Contributors
Author: Schukken, Y. H.
Author: Zadoks, R. N.
Author: Barkema, H. W.
Date Issued
2006
Abstract

Staphylococcus aureus is an important cause of udder infections in dairy herds. Both lactational and dry cow therapy are part of Staph. aureus control programs. Reported cure rates for Staph. aureus mastitis vary considerably. The probability of cure depends on cow, pathogen, and treatment factors. Cure rates decrease with increasing age of the cow, increasing somatic cell count, increasing duration of infection, increasing bacterial colony counts in milk before treatment, and increasing number of quarters infected. Staphylococcus aureus mastitis in hind quarters has a low cure rate compared with front quarters. Antimicrobial treatment of intramammary infections with penicillin-resistant Staph. aureus strains results in a lower cure rate for treatment with either beta-lactam or non-beta-lactam antibiotics. Other strain-specific factors may affect the probability of cure but routine diagnostic methods for use in bacteriology laboratories or veterinary practices are not yet available. The most important treatment factor affecting cure is treatment duration. Increased duration of treatment is associated with increased chance of cure. Economically, extended treatment is not always justified, even when indirect effects of treatment such as prevention of contagious transmission are taken into consideration. Usefulness of treatment trials could be improved by standardization of case definitions, consideration of host and strain factors, and sufficient statistical power. Treatment of young animals with penicillin-sensitive Staph. aureus infections is often justified based on bacteriological cure and economic outcome, whereas treatment of older animals, chronic infections, or penicillin-resistant isolates should be discouraged.

Note

Dept. of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI, Canada. barkema@upei.ca

United States

PUBM: Print; JID: 2985126R; 0 (Anti-Bacterial Agents); 0 (Penicillins); RF: 131; ppublish

Source type: Electronic(1)

Language

  • English

Subjects

  • Microbial Sensitivity Tests/economics/veterinary
  • Staphylococcus aureus
  • Clinical Trials/veterinary
  • Mastitis, Bovine/drug therapy/microbiology
  • Lactation
  • Aging
  • Costs and Cost Analysis
  • Penicillin Resistance
  • animals
  • cattle
  • Time Factors
  • Penicillins/therapeutic use
  • Anti-Bacterial Agents/administration & dosage/therapeutic use
  • Pregnancy
  • Cell Count
  • Drug Therapy, Combination
  • Milk/cytology
  • Staphylococcal Infections/drug therapy/microbiology/veterinary
  • Female
Page range
1877-1895
Host Title
Journal of Dairy Science
Host Abbreviated Title
J.Dairy Sci.
Volume
89
Issue
6
ISSN
1525-3198

Department